A controversial treatment for chronic opioid addiction has gained little traction in Canada in spite of some glowing reviews and federal support. Now Canada’s health minister is calling on Alberta to reconsider closing its program, which involves administering pharmaceutical-grade opioids in a clinical setting, sometimes several times a day.